Azaperone

CAS No. 1649-18-9

Azaperone( Azaperone | Stresnil | Azaperon | Fluoperidol )

Catalog No. M18105 CAS No. 1649-18-9

Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
25MG 33 In Stock
50MG 45 In Stock
100MG 67 In Stock
200MG 91 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Azaperone
  • Note
    Research use only, not for human use.
  • Brief Description
    Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine.
  • Description
    Azaperone is a dopamine antagonist. Azaperone is used mainly as a tranquilizer in veterinary medicine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Azaperone | Stresnil | Azaperon | Fluoperidol
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Kinesin
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1649-18-9
  • Formula Weight
    327.4
  • Molecular Formula
    C19H22FN3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL 152.72 mM;H2O : < 0.1 mg/mL
  • SMILES
    FC1=CC=C(C=C1)C(=O)CCCN1CCN(CC1)C1=CC=CC=N1
  • Chemical Name
    1-(4-Fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. SSL Tan, et al. Appl Anim Behav Sci, 1990, 26(1-2), 157-168.
molnova catalog
related products
  • BOS-172722

    BOS-172722 is an inhibitor of monopolar spindle 1 (MPS1) checkpoint(IC50 of 2 nM).

  • Merestinib

    LY2801653 is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineoplastic activity.

  • Kif15-IN-1

    Kif15-IN-1 is a potent, selective inhibitor of KIF15 motility, can act synergistically with Eg5 inhibitors to impair cancer cell proliferation.